| Trial ID: | L3756 |
| Source ID: | NCT01895569
|
| Associated Drug: |
Metformin
|
| Title: |
Triple Therapy in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Metformin|DRUG: Pioglitazone|DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Glycemic variability, Glycemic variability will be assessed at the baseline, and every three months, using a continuous glucose monitoring system., 9 months | Secondary: Glyco-metabolic control, Glyco-metabolic control will be assessed evaluating glycated hemoglobin, fasting plasma glucose and post-prandial glucose., 9 months | Other: Insulin-resistance parameters, Insulin-resistance parameters will be assessed using HOMA-index (HOMA-IR and HOMA-β)., 9 months
|
| Sponsor/Collaborators: |
Sponsor: University of Pavia | Collaborators: Fondazione IRCCS Policlinico San Matteo di Pavia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
64
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-06
|
| Completion Date: |
2016-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-10
|
| Locations: |
IRCCS Policlinico S. Matteo Foundation, Pavia, 27100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT01895569
|
